HAIC Combined With Toripalimab and Donafenib for Advanced BTC

NCT05350943 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Adenocarcinoma

Interventions

PROCEDURE: HAIC
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Toripalimab
DRUG: Donafenib

Sponsor

Lu Wang, MD, PhD